The refit model for end-stage liver disease-Na is not a better predictor of mortality than the refit model for end-stage liver disease in patients with cirrhosis and ascites

被引:4
|
作者
Kim, Jun Jae [1 ]
Kim, Jeong Han [1 ]
Koo, Ja Kyung [1 ]
Choi, Yun Jung [1 ]
Ko, Soon Young [1 ]
Choe, Won Hyeok [1 ]
Kwon, So Young [1 ]
机构
[1] Konkuk Univ, Sch Med, Digest Dis Ctr, Dept Internal Med, Seoul, South Korea
关键词
End Stage Liver Disease; Liver Cirrhosis; Ascites; Mortality; Hyponatremia;
D O I
10.3350/cmh.2014.20.1.47
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: The modification of the Model for End-Stage Liver Disease (MELD) scoring system (Refit MELD) and the modification of MELD-Na (Refit MELDNa), which optimized the MELD coefficients, were published in 2011. We aimed to validate the superiority of the Refit MELDNa over the Refit MELD for the prediction of 3-month mortality in Korean patients with cirrhosis and ascites. Methods: We reviewed the medical records of patients admitted with hepatic cirrhosis and ascites to the Konkuk University Hospital between January 2006 and December 2011. The Refit MELD and Refit MELDNa were compared using the predictive value of the 3-month mortality, as assessed by the Child-Pugh score. Results: In total, 530 patients were enrolled, 87 of whom died within 3 months. Alcohol was the most common etiology of their cirrhosis (n= 271, 51.1%), and the most common cause of death was variceal bleeding (n= 20, 23%). The areas under the receiver operating curve (AUROCs) for the Child-Pugh, Refit MELD, and Refit MELDNa scores were 0.754, 0.791, and 0.764 respectively; the corresponding values when the analysis was performed only in patients with persistent ascites (n= 115) were 0.725, 0.804, and 0.796, respectively. The significant difference found among the Child-Pugh, Refit MELD, and Refit MELDNa scores was between the Child-Pugh score and Refit MELD in patients with persistent ascites (P= 0.039). Conclusions: Refit MELD and Refit MELDNa exhibited good predictability for 3-month mortality in patients with cirrhosis and ascites. However, Refit MELDNa was not found to be a better predictor than Refit MELD, despite the known relationship between hyponatremia and mortality in cirrhotic patients with ascites.
引用
收藏
页码:47 / 55
页数:9
相关论文
共 50 条
  • [41] The model for end-stage liver disease predicts outcomes in patients undergoing cholecystectomy
    Scott C. Dolejs
    Joal D. Beane
    Joshua K. Kays
    Eugene P. Ceppa
    Ben L. Zarzaur
    Surgical Endoscopy, 2017, 31 : 5192 - 5200
  • [42] Safety of regadenoson in patients with end-stage liver disease
    AlJaroudi, Wael
    Iqbal, Fahad
    Koneru, Jayanth
    Bhambhvani, Pradeep
    Heo, Jaekyeong
    Iskandrian, Ami E.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2011, 18 (01) : 90 - 95
  • [43] Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications
    Huo, TI
    Lin, HC
    Wu, JC
    Hou, MC
    Lee, FY
    Lee, PC
    Chang, FY
    Lee, SD
    CLINICAL TRANSPLANTATION, 2006, 20 (02) : 188 - 194
  • [44] Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score
    Angermayr, B.
    Luca, A.
    Konig, F.
    Bertolini, G.
    Ploner, M.
    Gridelli, B.
    Ulbrich, G.
    Reiberger, T.
    Bosch, J.
    Peck-Radosavljevic, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (01) : 65 - 71
  • [45] The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis
    Morimoto, Naoto
    Okada, Kenji
    Okita, Yutaka
    ANNALS OF THORACIC SURGERY, 2013, 96 (05) : 1672 - 1678
  • [46] Nutrition in pediatric end-stage liver disease
    Desai, Tejas S.
    Hulst, Jessie M.
    Bandsma, Robert
    Mehta, Sagar
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2024, 27 (06) : 492 - 498
  • [47] End-stage renal disease in liver transplants
    Lynn, M
    Abreo, K
    Zibari, G
    McDonald, J
    CLINICAL TRANSPLANTATION, 2001, 15 : 66 - 69
  • [48] MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era
    Kim, W. Ray
    Mannalithara, Ajitha
    Heimbach, Julie K.
    Kamath, Patrick S.
    Asrani, Sumeet K.
    Biggins, Scott W.
    Wood, Nicholas L.
    Gentry, Sommer E.
    Kwong, Allison J.
    GASTROENTEROLOGY, 2021, 161 (06) : 1887 - +
  • [49] Sarcopenia in Children With End-Stage Liver Disease
    Lurz, Eberhard
    Patel, Hiten
    Frimpong, Richard G.
    Ricciuto, Amanda
    Kehar, Mohit
    Wales, Paul W.
    Towbin, Alexander J.
    Chavhan, Govind B.
    Kamath, Binita M.
    Ng, Vicky L.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2018, 66 (02) : 222 - 226
  • [50] Kidney function and mortality post-liver transplant in the Model for End-Stage Liver Disease era
    Sethi, Aastha
    Estrella, Michelle M.
    Ugarte, Richard
    Atta, Mohamed G.
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2011, 4 : 139 - 144